about
Characterization and quantification of cerebral edema induced by synchrotron x-ray microbeam radiation therapy.Revised rates for the stellar triple-alpha process from measurement of 12C nuclear resonances.Synchrotron-generated microbeam sensorimotor cortex transections induce seizure control without disruption of neurological functionsSynchrotron radiation in cancer treatments and diagnostics: an overview.Carbon and oxygen minibeam radiation therapy: An experimental dosimetric evaluation.Better Efficacy of Synchrotron Spatially Microfractionated Radiation Therapy Than Uniform Radiation Therapy on Glioma.Study of the biochemical effects induced by X-ray irradiations in combination with gadolinium nanoparticles in F98 glioma cells: first FTIR studies at the Emira laboratory of the SESAME synchrotron.Analysis of platinum and trace metals in treated glioma rat cells by X-ray fluorescence emission.Double-strand breaks on F98 glioma rat cells induced by minibeam and broad-beam synchrotron radiation therapy.Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.Increase of lifespan for glioma-bearing rats by using minibeam radiation therapy.Survival analysis of F98 glioma rat cells following minibeam or broad-beam synchrotron radiation therapy.Development and commissioning of a Monte Carlo photon beam model for the forthcoming clinical trials in microbeam radiation therapy.Measurement of carbon ion microdosimetric distributions with ultrathin 3D silicon diodes.A new method of creating minibeam patterns for synchrotron radiation therapy: a feasibility study.Proton minibeam radiation therapy: Experimental dosimetry evaluation.Proton minibeam radiation therapy spares normal rat brain: Long-Term Clinical, Radiological and Histopathological Analysis.Transfer of Minibeam Radiation Therapy into a cost-effective equipment for radiobiological studies: a proof of concept.Synchrotron X-ray interlaced microbeams suppress paroxysmal oscillations in neuronal networks initiating generalized epilepsy.Optimization of the mechanical collimation for minibeam generation in proton minibeam radiation therapy.Dosimetric evaluation of new approaches in GRID therapy using nonconventional radiation sources.X-ray energy optimization in minibeam radiation therapy.Gadolinium dose enhancement studies in microbeam radiation therapy.Dose evaluation of Grid Therapy using a 6 MV flattening filter-free (FFF) photon beam: A Monte Carlo study.Preclinical radiotherapy at the Australian Synchrotron's Imaging and Medical Beamline: instrumentation, dosimetry and a small-animal feasibility study.Spatial fractionation of the dose using neon and heavier ions: A Monte Carlo study.Monte Carlo-based dose calculation engine for minibeam radiation therapy.Evaluation of the local dose enhancement in the combination of proton therapy and nanoparticles.Spatial fractionation of the dose in heavy ions therapy: An optimization study.Heterogeneous intratumoral distribution of gadolinium nanoparticles within U87 human glioblastoma xenografts unveiled by micro-PIXE imaging.Theoretical dosimetric evaluation of carbon and oxygen minibeam radiation therapy.Minibeam radiation therapy for the management of osteosarcomas: a Monte Carlo study.Impact of cardiosynchronous brain pulsations on Monte Carlo calculated doses for synchrotron micro- and minibeam radiation therapyShell Structure of the Near-Dripline NucleusO23Proton minibeam radiation therapy widens the therapeutic index for high-grade gliomasDosimetry protocol for the forthcoming clinical trials in synchrotron stereotactic radiation therapy (SSRT)Clarification of the Three-Body Decay ofC12(12.71 MeV)Translational research in radiobiology in the framework of France HADRON national collaborationTolerance to Dose Escalation in Minibeam Radiation Therapy Applied to Normal Rat Brain: Long-Term Clinical, Radiological and Histopathological AnalysisProton-minibeam radiation therapy: a proof of concept
P50
Q31147607-E1E3BD40-481C-4CDD-B499-050752C8EA94Q34384427-FD222DE4-9A5C-43EB-99EA-417FFCE2F7F7Q34558492-E65D0C36-A9F6-4F8C-BF6C-EF31798BF79EQ37942735-3B2D2DD6-7E1D-45FB-8B40-BB53D5F2B2A2Q38677486-59D43912-73EB-47F8-9006-C9F6028FE941Q38763147-23062DAF-DF05-4A95-A7C4-E5AD9AF0226BQ38789733-18C50CD8-09CF-4328-B942-42F7EE3CE3F7Q38957045-0633F34C-4C46-4400-A670-EAA54C1BE7B0Q39056161-0A9C439D-AACB-44AC-B8DF-D26A4EE5987CQ39234458-A2510AC8-F7E0-472B-9A83-30B5A00CB82CQ39424865-B7C11751-1D0E-4908-99C2-2893690E63ACQ39559379-949F8D3C-6CDF-41B8-9454-9235EF042CEDQ39667023-A1099DAD-8723-4021-B605-819C969CF72BQ39779067-1D66E9F3-68B7-411C-AC9B-8249C3478F73Q39970205-48B93639-A056-48A8-AAB4-12438C72F6E0Q40247290-319A0681-61CB-4C3A-80F2-77A39CC60CD9Q44554121-555484DA-3CE8-47DE-91DB-1501187DF26BQ47099771-DDDC584C-ED86-4977-892A-99CCFD1CE0C3Q48291453-4E10889A-8A94-46B0-A3B4-670294E65C81Q48336585-15371CF9-8A80-4716-B298-F09B325BBAA6Q48343655-64C1D3EC-6E0B-4427-9574-7563023F3F65Q48385204-53E85E11-EBB2-46F3-BFB5-219DD81F0D2BQ48461906-92BF129B-CBE3-4494-B2D9-FB56F56DA507Q48714113-7BE3D63A-5F93-42B3-8CE3-8957B120DE08Q50552885-6DDABF19-0B53-4566-8062-1E9E8D8D6032Q50928637-58D3B659-8FFF-4485-8C7F-A0EEFACE7C14Q51597086-C786B252-46F9-4F49-9A38-7298FA5A9C1DQ51664376-89FD1FAE-CCA9-4411-9C6F-34D5C0D4D7ECQ52597209-431759E9-6C05-427D-8559-BF7386A2E181Q52903483-0D8704A8-2F4D-416C-968F-A93A24E8D3EBQ53520507-EB59FF7B-8EBF-4D4B-87C0-F9F642BEF468Q53538619-BB652997-138B-4F37-A025-E888D28B2F1BQ57178659-D3BE53B9-0A89-4547-9A81-13DBBB07A761Q57676125-83DF3763-3CC8-467A-9B8F-A252446AAC7AQ58602595-CD2D4CB0-FC55-4C43-9265-7CA4538313CFQ59291222-C2E4A1EF-720D-486A-BED8-A708967D5BB0Q60529274-A925E480-68F6-4234-938C-2A339AF8CCD0Q63966759-91C3CCB0-16D6-43BF-89DB-496085182246Q85922758-F5ED5CF6-EF4E-4E30-A530-24D008BA2137Q86287330-FC31CF91-5B9A-4AF9-BF8E-0EADDA64E513
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yolanda Prezado
@ast
Yolanda Prezado
@en
Yolanda Prezado
@es
Yolanda Prezado
@nl
type
label
Yolanda Prezado
@ast
Yolanda Prezado
@en
Yolanda Prezado
@es
Yolanda Prezado
@nl
prefLabel
Yolanda Prezado
@ast
Yolanda Prezado
@en
Yolanda Prezado
@es
Yolanda Prezado
@nl
P106
P1153
6602488124
P31
P496
0000-0001-5957-2327